Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207350 · ClinicalTrials.gov registry record · NA
Neurosurgical Use of Interstitial Laser Therapy (ILT)
A NA study of Brain Tumor, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT00207350: Completed NA study of Brain Tumor, sponsored by Brigham and Women's Hospital.
NCT00207350 is a NA study of Brain Tumor that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6 participants, below the 282-participant average among 69 other Brain Tumor trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00207350, a NA study of Brain Tumor, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers' specific aims are to test the following hypotheses: Hypothesis 1: A tumor can be completely ablated by ILT with MRI-guidance. Hypothesis 2: The MRI-based 3D temperature map of tissue during ILT is predictive of destruction. Hypothesis 3: The 3D "thermal dose" map that is based on the tissue's temperature over time is more predictive of tissue destruction than the temperature map.
Conditions Studied
Interventions
- DEVICE Interstitial Laser Therapy
Study Locations (1)
Massachusetts
- Brigham & Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2002-01 |
| Est. Completion | 2006-12 |
| Phase | NA |
What the finished NCT00207350 record still lists
NCT00207350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 282-participant average among 69 other Brain Tumor trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Interstitial Laser Therapy is the first listed.
NCT00207350 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00207350 about?
NCT00207350 is a clinical study titled "Neurosurgical Use of Interstitial Laser Therapy (ILT)". The researchers' specific aims are to test the following hypotheses: Hypothesis 1: A tumor can be completely ablated by ILT with MRI-guidance. Hypothesis 2: The MRI-based 3D temperature map of tissue during ILT is predictive of destruction. Hypothesis 3: The 3D "thermal dose" map that is based on...
What is the current status of trial NCT00207350?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2002-01. Estimated completion is 2006-12.
What conditions does trial NCT00207350 study?
This clinical trial studies the following conditions: Brain Tumor.
What interventions are being tested in trial NCT00207350?
The interventions under investigation include: Interstitial Laser Therapy (DEVICE).
Who is sponsoring clinical trial NCT00207350?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00207350 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00207350's enrollment target sits among peer trials
6 68th of 69 higher than 1 of 69 other Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia